SNY: Multiplikator rega marang pendapatan Sanofi Aventis

Logo korporat perusahaan Sanofi Aventis (SNY)

Regarding the price-to-sales ratio, this chart on GURU.Markets shows that the metric is fixed at 2.20. Patent barriers and costly biotechnologies serve as a moat for the business. A network of modern plants in the US and Europe guarantees production stability. Monopoly rights to unique therapies allow Sanofi (SNY) to maintain its premium pricing power.

Sanofi (SNY): Multiplikator P/S saka 04.07.2022 nganti 13.11.2026

Rincian metrik lan analitis perusahaan Sanofi Aventis (SNY)

- rega saham lan target rega konsensus:
Kurs saham sanofi.com|SNY - Prakiraan konsensus analis
- informasi kapitalisasi pasar:
Kapitalisasi pasar Sanofi Aventis|SNY - Nilai Total Perusahaan
- data kapitalisasi buku:
Aset Bersih saben Saham Sanofi|SNY - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku sanofi.com|SNY - Aset Agregat Perusahaan
- indikator beban kredit lan likuiditas emiten:
Rasio Utang marang Ekuitas Sanofi|SNY - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal Sanofi Group|SNY - Gunggung utang perusahaan|Rasio utang-utang marang kapitalisasi buku Sanofi Aventis|SNY - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Sanofi|Koefisien jangkoan perantara sanofi.com
- data bathi resik lan rasio valuasi:
SNY - Bathi resik perusahaan|Prakiraan bathi resik Sanofi|SNY - Koefisien rega marang bathi|Rasio prakiraan rega marang bathi Sanofi SA|SNY - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan Sanofi Aventis|SNY - Bathi operasional EBITDA|Bathi saben saham sajroning taun lumaku Sanofi|SNY - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan sanofi.com|SNY - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep Sanofi
- rincian pendapatan lan dodolan emiten:
SNY - Pendapatan perusahaan|Volume dodolan mangsa ngarep perusahaan sanofi.com|SNY - Multiplikator P/S|Multiplikator Forward P/S Sanofi Aventis
Analisis umum perusahaan:sanofi.com - SNY
Produk sing diprodhuksi Sanofi S.A.

The P/S ratio determines the market value of Sanofi (SNY) relative to its annual revenue, measuring the premium investors are willing to pay for every euro of sales. For this veteran European manufacturer of vaccines and life-saving medicines, the price/sales ratio trend serves as an indicator of how closely the market valuation aligns with real commercial resilience and global trust in the company's brand.

Perusahaan pesaing

lilly.com - Rasio kapitalisasi marang pendapatan|Multiplikator P/S ABBV (AbbVie)|Multiplikator rega marang pendapatan AstraZeneca Plc|NVS - Rasio rega marang pendapatan|Koefisien rega marang pendapatan MSD MRK|NVO: Multiplikator P/S|amgen.com (AMGN) - Multiplikator P/S|Rasio rega marang pendapatan Pfizer|Rasio kapitalisasi marang pendapatan BMY (Bristol Myers Squibb Company)|Rasio rega marang pendapatan GSK plc (GSK)|TAK - Rega marang dodolan|Multiplikator P/S TEVA (Teva Pharmaceutical Industries)|RDY (drreddys.com) - Rasio rega marang dodolan|Viatris - Multiplikator P/S|Koefisien rega marang pendapatan Roivant ROIV|Zai Lab Ltd. (ZLAB) - Rasio rega marang pendapatan|BHC - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Cosmos Health Inc.